High‐throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome

Abstract

AbstractBackgroundPrevious investigations pointed out a role for antigen stimulation in Sezary syndrome (SS). High‐throughput sequencing of the T cell receptor (TR) offers several applications beyond diagnostic purposes, including the study of T cell pathogenesis.MethodsWe performed high‐throughput RNA sequencing of the TR alpha (TRA) and beta (TRB) genes focusing on the complementarity‐determining region 3 (CDR3) in 11 SS and one erythrodermic mycosis fungoides (MF) patients. Five psoriasis patients were employed as controls. Peripheral blood CD4+ cells were isolated and RNA sequenced (HiSeq2500). High‐resolution HLA typing was performed in neoplastic patients.ResultsHighly expanded predominant TRA and TRB CDR3 were only found in SS patients (median frequency: 94.4% and 93.7%). No remarkable CDR3 expansions were observed in psoriasis patients (median frequency of predominant TRA and TRB CDR3: 0.87% and 0.69%, p < 0.001 compared to SS). CDR3 almost identical to the predominant were identified within each SS patient and were exponentially correlated with frequencies of the predominant CDR3 (R2 = 0.918, p < 0.001). Forty‐six different CDR3 were shared between SS patients displaying HLA similarities, including predominant TRA and TRB CDR3 in one patient that were found in other three patients. Additionally, 351 antigen matches were detected (Cytomegalovirus, Epstein–Barr, Influenza virus, and self‐antigens), and the predominant CDR3 of two different SS patients matched CDR3 with specificity for Influenza and Epstein–Barr viruses.ConclusionsBesides detecting clonality, these findings shed light on the nature of SS‐related antigens, pointing to RNA sequencing as a useful tool for simultaneous clonality and biological analysis in SS.